Jeffrey Schuster

Jeffrey Schuster has a diverse work experience spanning several roles and organizations. Jeffrey is currently serving as the Chief Technology Officer at Miist Therapeutics since January 2022. Prior to that, they operated their own consulting firm, Jeffrey Arthur Schuster, Ph.D. Consulting, where they worked as a consultant since February 2007. Jeffrey also held the position of Chief Technology Officer at Diagnose Early from January 2019 to July 2019.

Before entering the consulting field, Jeffrey served as the CEO of Oscillari LLC, a company focused on developing a monitor for drug delivery devices. Jeffrey held this role from May 2013 to January 2019. Additionally, Jeffrey worked as a Consultant at Triple Ring Technologies from June 2008 to June 2013.

Jeffrey has also held leadership positions in the pharmaceutical industry, including serving as the President of Respire Pharmaceuticals from February 2007 to February 2008. Prior to that, Jeffrey worked as a Senior Director at Aradigm Corporation from 1994 to 2007.

Overall, Jeffrey Schuster's work experience showcases their expertise in technology, consulting, and pharmaceutical industries.

Jeffrey Schuster obtained a Bachelor of Arts (BA) degree in Physics from the University of California, Berkeley, from 1982 to 1986. Following this, they pursued a Ph.D. in Physics at the same university, completing their doctoral studies from 1986 to 1993.